Thank you ⁦Johnson & Johnson Innovation⁩ ⁦Johnson & Johnson⁩ for hosting ⁦AdvaMed⁩ compliance leaders today! Committed to patients and Ethics!

Packed house as #medtech compliance leaders convene for ⁦AdvaMed⁩ compliance meetings. Thank you ⁦Johnson & Johnson Innovation⁩ ⁦Johnson & Johnson⁩ for hosting!

Every Congress & every Administration talks about the importance of driving medical innovation & increasing patient access to care. So we created a policy blueprint to help them accomplish exactly that. Let’s get to work on this list, starting today: advamed.org/2023/02/28/adv…

Glad to be working with AdvaMed to help improve patient access and care of life saving medical devices.

#News: Today AdvaMed announced that Ashley McEvoy, Executive Vice President and Worldwide Chairman of MedTech at Johnson & Johnson, was elected Chair of the AdvaMed Board of Directors. Read more: bit.ly/40Gyaf9 #JNJMedTechProud

Great talk from Former Federal Reserve Vice Chair Roger Ferguson at the #CEOSummit this morning. “If I were 25 and could do it over again, I would choose a career in medtech…”

.@JNJMedtech’s Ashley McEvoy has a long history of leadership in the medtech industry, and it has prepared her well to lead our AdvaMed Board as Chair. I look forward to working with her and the Board on behalf of the patients we serve. advamed.org/industry-updat…

Very cool opportunity to speak with 𝐃𝐚𝐦𝐚𝐫 𝐇𝐚𝐦𝐥𝐢𝐧 at our CEO Summit. What an inspirational guy, on and off the field. Disciplined. Entrepreneurial. Humble. Thanks for joining us and for inspiring our entire country with your amazing recovery, Damar.

Thanks to my AdvaMed colleague Ida Nassar for leading our legal policy work on FTC's overbroad noncompete rulemaking. See my blog here: FTC’s Non-Compete Agreement Rulemaking Puts Medtech Innovation and Patient Access to New Treatments at Risk linkedin.com/feed/update/ur…

AdvaMed’s General Counsel and Chief Policy Officer, Chris White, explains why the Federal Trade Commission’s proposed rule on non-compete agreements could hurt patients. advamed.org/2023/04/03/ftc… #patientaccess #medtech

Yikes! Investor-driven litigation — patients beware! See my blog on this concerning trend. @advamedupdate advamed.org/2023/04/13/shi…

I'm so proud to work with leaders such as those featured here, committed to ethics, patients and medical innovation. Join us in celebrating 30 years of medtech's compass, navigating innovation for patients everywhere. AdvaMed advamed.org/2023/05/12/the…

Thank you ⁦Medmarc Insurance⁩ for long-standing support of medtech and patients everywhere. Honored to present at your medtech leadership meetings today. ⁦AdvaMed⁩

My view from the podium. Thanks ⁦Medmarc Insurance⁩ for convening medtech summit & support of ⁦AdvaMed⁩ Frivolous litigation corrodes innovation and impedes patient access to lifesaving technologies.

Looking forward to @PavMedInc/Lucid Diagnostics CEO and member of the AdvaMed Board Dr. Lishan Aklog’s testimony before the House E&C health subcommittee today on the need for Congress to pass #TCET legislation. 1/

Ever wonder why you see so many legal ads? Hidden financiers subsidize ads to spur litigation. When that happens, patients are at risk. AdvaMed

ICYMI: AdvaMed's comments on third-party litigation funding were read into the record during a House Oversight Committee hearing last week. Read the full letter: advamed.org/wp-content/upl…

Interested in #medtech? This deserves top position on your playlist! Better yet--join medtech leaders convening in LA next week for #MedtechCon. AdvaMed podcasts.apple.com/us/podcast/con…

Interested in #medtech? This deserves top position on your playlist! Better yet--join our conference in LA next week and meet with medtech leaders convening with AdvaMed podcasts.apple.com/us/podcast/con…

Litigation Financing puts patients at risk + chills innovation--my blog describes why. We'll explore this trend in expert legal panels next week at #MedTechCon. @advamedupdate advamed.org/2023/10/03/an-…